1. Home
  2. AGH vs CHRO Comparison

AGH vs CHRO Comparison

Compare AGH & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGH
  • CHRO
  • Stock Information
  • Founded
  • AGH 2014
  • CHRO 2002
  • Country
  • AGH United States
  • CHRO United States
  • Employees
  • AGH N/A
  • CHRO 11
  • Industry
  • AGH
  • CHRO
  • Sector
  • AGH
  • CHRO
  • Exchange
  • AGH NYSE
  • CHRO Nasdaq
  • Market Cap
  • AGH 8.5M
  • CHRO 7.6M
  • IPO Year
  • AGH 2025
  • CHRO 2024
  • Fundamental
  • Price
  • AGH $0.59
  • CHRO $1.35
  • Analyst Decision
  • AGH
  • CHRO
  • Analyst Count
  • AGH 0
  • CHRO 0
  • Target Price
  • AGH N/A
  • CHRO N/A
  • AVG Volume (30 Days)
  • AGH 122.2K
  • CHRO 132.3K
  • Earning Date
  • AGH 05-15-2025
  • CHRO 08-12-2025
  • Dividend Yield
  • AGH N/A
  • CHRO N/A
  • EPS Growth
  • AGH N/A
  • CHRO N/A
  • EPS
  • AGH N/A
  • CHRO N/A
  • Revenue
  • AGH $3,073,097.00
  • CHRO N/A
  • Revenue This Year
  • AGH N/A
  • CHRO N/A
  • Revenue Next Year
  • AGH N/A
  • CHRO N/A
  • P/E Ratio
  • AGH N/A
  • CHRO N/A
  • Revenue Growth
  • AGH N/A
  • CHRO N/A
  • 52 Week Low
  • AGH $0.52
  • CHRO $0.45
  • 52 Week High
  • AGH $7.22
  • CHRO $3.80
  • Technical
  • Relative Strength Index (RSI)
  • AGH N/A
  • CHRO 63.60
  • Support Level
  • AGH N/A
  • CHRO $1.12
  • Resistance Level
  • AGH N/A
  • CHRO $1.23
  • Average True Range (ATR)
  • AGH 0.00
  • CHRO 0.16
  • MACD
  • AGH 0.00
  • CHRO 0.01
  • Stochastic Oscillator
  • AGH 0.00
  • CHRO 30.26

About AGH AUREUS GREENWAY HOLDINGS INC

Aureus Greenway Holdings Inc own and operate two public golf country clubs in Florida. The golf country clubs include two golf-courses with over 13,000 yards of combined fairways, clubhouses boasting food and beverage options, aquatic golf ranges, and pro shops to assist any level of golfer and also host local golf leagues, golf-tournaments, and private events. Its golf country clubs is organized into four principal business segments: (i) golf recreation, retail golf products, and equipment and facilities rental, (ii) membership dues, (iii) food and beverage services. and (iv) ancillary services and amenities. All assets of the Company are located in Florida and all revenue is generated from Florida.

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

Share on Social Networks: